WeVote
Log In

Bill

Bill

S 4002

Relates to establishing an automatic expunction system for certain records

2025 Regular Session Introduced by Kevin Parker

Prohibits sale of cosmetic and personal care products containing 1,4-dioxane beyond set trace limits, with waivers and a plan to tighten standards over time.

REFERRED TO CODES
0
WeVote Research Nonpartisan
Bill Summary · S 4002

Summary of New Jersey Bill S 4002

Overview

  • Bill: S 4002
  • Title: Relates to establishing an automatic expunction system for certain records (note: the introduced content provided describes a separate environmental health measure concerning 1,4-dioxane in cosmetics)
  • Status: Referred to Codes (introduced January 14, 2025)
  • Primary Sponsor: Kevin S. Parker
  • Related/Labeled as: Companion bills include A 6013 (and others listed)

Note on the introduced text: The bill text provided focuses on prohibiting the sale of cosmetic and personal care products containing 1,4-dioxane and establishing trace-concentration standards, rather than an automatic expunction system. The summary below reflects the substantive provisions in the introduced version presented.

Purpose and intent

  • Prohibit sale of cosmetic and personal care products containing 1,4-dioxane.
  • Establish a regulatory framework to limit 1,4-dioxane in consumer products, protect human health and the environment, and provide a pathway for manufacturers to obtain temporary waivers if they are unable to fully comply.

Key provisions

  • Definitions (Section 1a)

    • Commissioner: Commissioner of Environmental Protection.
    • Department: New Jersey Department of Environmental Protection (NJ DEP).
    • Cosmetic product: Any article applied to the human body for beautification/appearance, excluding prescription-required products.
    • Personal care product: Products for cleaning the body (e.g., shampoo, soap), excluding prescription-required items.

  • Prohibition and effective dates (Section 1b)

    • Beginning one year after the effective date, no sale of cosmetic or personal care products containing 1,4-dioxane (except trace concentrations approved by the Commissioner under subsection c).

  • Allowable trace concentrations (Section 1c)

    • Cosmetic products: up to 10 parts per million (ppm).
    • Personal care products: up to 2 ppm for the first two years after the effective date; after two years, up to 1 ppm.

  • Review and potential tightening (Section 1d)

    • By three years after the effective date, the Commissioner must review the standards and determine whether concentrations should be lowered.

  • Waivers for manufacturers (Section 1e)

    • Manufacturers may apply for a one-year waiver for a specific product if they have taken steps to reduce 1,4-dioxane but cannot comply.
    • A second one-year waiver may be granted under similar proof.

  • Rulemaking authority (Section 2)

    • DEP to adopt rules and regulations under the Administrative Procedure Act to implement the act.

  • Effective date (Section 3)

    • The act takes effect immediately.

Impact and affected parties

  • Affected products: Cosmetic products and personal care products sold in New Jersey that contain 1,4-dioxane.
  • Manufacturers/brand owners: Required to ensure products meet the specified trace-concentration limits or apply for waivers; may need to adjust manufacturing processes (e.g., vacuum stripping techniques).
  • Regulators: NJ DEP to enforce limits, set allowable trace concentrations, and issue waivers; to propose and finalize regulations.

Procedural/timeline aspects

  • Prohibitions begin one year after enactment.
  • Initial trace-concentration limits apply immediately after the effective date.
  • A three-year review is required to assess potential tightening.
  • Waiver process allows up to two one-year waivers per product, contingent on demonstrated steps to reduce 1,4-dioxane.

Context and related legislation

  • Modelled on New York’s Chapter 613 (2019), which similarly restricts 1,4-dioxane in cosmetics/personal care products.
  • Related companion bills and prior-session references exist (e.g., A 6013, S 7970, S 3198, S 3031, S 4680, A 4962).

This bill aims to reduce exposure to a known contaminant by setting explicit thresholds, enabling regulatory oversight, and providing a phased pathway for industry compliance.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.